# clm_0A05777F6B3A

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: revenue  
value: 13,117,200,000 United States dollar  
valid_from: 2023-12-31  
valid_to: 2024-12-31  
published: 2024-02-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_EE95AAD2339E  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals revenue: 13,117,200,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_0A05777F6B3A, https://asof.is/claim/clm_0A05777F6B3A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2023, filed 2024-02-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm (primary, SEC EDGAR 10-K FY2023, published 2024-02-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 12,172,900,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_0A05777F6B3A](/claim/clm_0A05777F6B3A.md) | [clm_6E857BE187DF](/claim/clm_6E857BE187DF.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.